Sign Up to like & get
recommendations!
1
Published in 2019 at "Biotechnology Progress"
DOI: 10.1002/btpr.2819
Abstract: Staphylokinase (SAK) is a promising thrombolytic agent for the treatment of patients suffering from blood‐clotting disorders. To increase the potency of SAK and to minimize vessel reocclusion, a new construct bearing SAK motif fused to…
read more here.
Keywords:
2rgd tti;
sak 2rgd;
staphylokinase sak;
expression ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Biotechnology Letters"
DOI: 10.1007/s10529-019-02748-5
Abstract: Objective Thrombin, platelets, and plasmin are three key factors involved in hemostasis and thrombolysis. Thrombolytic therapy with clinically approved drugs is often followed by recurrent thrombosis caused by thrombin-induced platelet aggregation from the clot debris.…
read more here.
Keywords:
clot;
2rgd tti;
staphylokinase;
designing multifunctional ... See more keywords